News
Kymos wins Biosuccess Award for consolidation and international expansion as science services company
The awards ceremony was held during the CataloniaBio & HealthTech Gala, shared via live streaming. Judit Anido, president of CataloniaBio & HealthTech: “We need more success stories like Kymos. One of the biggest challenges we (...) Read more
Kymos and Prolytic merge to become Kymos Group
With the German CRO joining the European group, Kymos will strengthen its activity in the biologics and advanced therapies market and broaden its services portfolio while offering three local sites in Europe Barcelona, Spain, (...) Read more
Biopharmaceutical Global Partners
Meet Pablo Cobo: KYMOS’ key opinion leader in biologics drug development Our head of Biopharmaceutical Testing Pablo Cobo, Chemistry graduate and biologics pioneer, remembers his early days at Ipsen when peptide product development was quite (...) Read more
ANIMAL CLINICAL R&D IN TIMES OF COVID-19
The COVID-19 pandemic has paralyzed many aspects of our lives. However, the R&D of new pharmaceutical products for animal health cannot stop as many human diseases posing a threat have an animal origin. KYMOS (...) Read more
